コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 reas the other also couples effectively to a G protein.
2 1-bound CRF1R and CRF2R with the stimulatory G protein.
3 ations in G protein-coupled receptors and/or G proteins.
4 al GTP-recognition mechanism employed by all G proteins.
5 ownstream from receptors that signal through G proteins.
7 roteins bind to activated Galpha subunits in G-proteins, accelerate the GTP hydrolysis, and thereby r
9 nstead, LOV2GIVe consists of the fusion of a G-protein activating peptide derived from a non-GPCR reg
10 ation studies revealed much slower rates for G protein activation by the GCGR compared with the beta(
17 resulting from acetylcholine stimulation and G-protein activation resulting from dopaminergic stimula
21 he encoded proteins exhibit highly conserved G-protein activities while showing expression differenti
25 d 2) in the allosteric activation mechanism, G protein allosterically triggers an increase in the spe
26 e Factor (GEF) that activates heterotrimeric G protein alpha subunits (Galpha) and serves as an essen
29 conventional ternary complex that activates G proteins and an inverse-coupled binary complex that ma
31 outcomes while utilizing a limited array of G proteins and effectors is poorly understood, particula
33 GPR88 inhibits the activation of both their G protein- and beta-arrestin-dependent signaling pathway
38 1) In the membrane recruitment mechanism, G protein association increases the density of active ki
39 ependently after ingestion of 15, 30, and 45 g protein at 360 min postexercise (0.018 +/- 0.002, 0.03
40 interactions of GRK2 with receptors or with G protein beta-gamma subunits which are differentially p
41 tive wild isolates, and deletion of the only G-protein beta-subunit-encoding gene of A. oligospora ne
42 of phospholipase Cbeta (PLCbeta) enzymes by G protein betagamma subunits from activated Galpha(i)-Gb
43 mulations to determine how arrestin bias and G protein bias arise at the angiotensin II type 1 recept
46 s represent mechanistically novel, extremely G protein-biased agonists is in question, as is the unde
50 is shifted by more than 20 angstrom and the G-protein-binding site is a shallow groove rather than a
51 roteins were originally reported to modulate G proteins by binding Galpha subunits of the G(i/o) fami
52 a mechanism of activation of heterotrimeric G proteins by RTKs and chart the key steps that mediate
53 ain, reflecting smaller amplification in the G-protein cascade; (2) a faster rate of turnover of the
54 hat is kinetically embedded between receptor-G protein complex rearrangements and G protein activatio
56 n this system involves two distinct receptor-G protein complexes, a conventional ternary complex that
63 g cholangiocyte proliferation via GHS-R1a, a G-protein coupled receptor which causes increased intrac
65 activated-receptor alpha (PPARalpha) and the G-protein coupled receptor, GPR119] and upstream (a fatt
68 ion frequency, RNA-i against seven out of 35 G-protein coupled receptors (GPCRs) within the germline
69 cells lacking leucine-rich repeat-containing G-protein coupled receptors (LGRs) 4, 5 and 6 (Lebensohn
70 ransient receptor potential ion channels and G-protein coupled receptors play important roles in itch
71 re mediated largely through their downstream G-protein coupled receptors through cAMP-PKA signaling.
72 ccelerators for activated Galpha subunits of G-protein coupled receptors, but they may also modulate
73 and, given that this peptide signals through G-protein coupled receptors, this signalling pathway pro
75 gnal nutrient availability by activating the G protein-coupled bile acid receptor 1 (GPBAR1, also cal
76 we show that ADGRE2/EMR2 and ADGRE5/CD97 are G protein-coupled in a variety of recombinant systems.
77 are mediated by the class B calcitonin-like G protein-coupled receptor (CLR), which heterodimerizes
83 like peptide-1 receptor (GLP1R) is a class B G protein-coupled receptor (GPCR) involved in metabolism
84 identified novel eNOS interactors, including G protein-coupled receptor (GPCR) kinase interactor 1 (G
86 ign 'biased' drugs that selectively activate G protein-coupled receptor (GPCR) signaling pathways ben
87 ng techniques has revealed that mutations in G protein-coupled receptor (GPCR) signaling pathways in
88 me label-free techniques are used to profile G protein-coupled receptor (GPCR) signaling pathways in
91 de hormone glucagon is a seven-transmembrane G protein-coupled receptor (GPCR) that regulates blood g
92 commonly used opioids, and is a prototypical G protein-coupled receptor (GPCR) where new pharmacologi
94 MC4R is revealed as a structurally divergent G protein-coupled receptor (GPCR), with more similarity
95 dopsin is a canonical class A photosensitive G protein-coupled receptor (GPCR), yet relatively few ph
98 ection of two putative fatty acid receptors, G protein-coupled receptor 120 (GPR120) and cluster of d
99 more complicated with the identification of G protein-coupled receptor 30 (GPR30), an estrogen recep
100 ria, supports leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5)(+) intestinal stem c
102 he specific function of SMC-expressed orphan G protein-coupled receptor class C group 5 member B (GPR
103 nderstanding of ligand-gated ion channel and G protein-coupled receptor complexes and discuss strateg
107 ed decrease in the hepatic protein levels of G protein-coupled receptor kinase 2 (GRK2), an important
108 rase 4D (PDE4D) through transactivation of a G protein-coupled receptor kinase 2 (GRK2)-dependent bet
113 ike peptide-1 receptor (GLP-1R) is a class B G protein-coupled receptor that plays an important role
115 uble protein calmodulin, ligand binding to a G protein-coupled receptor, and activation of an ion cha
118 The experimental evidence that Adhesion G Protein-Coupled Receptors (aGPCRs) functionally couple
119 e and alternatively-spliced ECRs of adhesion G protein-coupled receptors (aGPCRs) have key functions
120 e diversity and near universal expression of G protein-coupled receptors (GPCR) reflects their involv
121 maceutical drugs targeting integral membrane G protein-coupled receptors (GPCR) requires thorough und
123 K2), an important negative modulator of both G protein-coupled receptors (GPCRs) and insulin signalin
146 uctural and spectroscopic studies of class A G protein-coupled receptors (GPCRs), such as rhodopsin a
147 st-based reporter strains for studying human G protein-coupled receptors (GPCRs), the largest class o
148 s ligand bias has been studied primarily for G protein-coupled receptors (GPCRs), there are also repo
150 ilon (PLCepsilon) is activated downstream of G protein-coupled receptors and receptor tyrosine kinase
155 The orexin system, which consists of the two G protein-coupled receptors OX(1) and OX(2), activated b
158 a pivotal role in the regulation of several G protein-coupled receptors that are essential for energ
159 ncer that centers on a negative regulator of G protein-coupled receptors that is downregulated in agg
161 teins, such as ligand-gated ion channels and G protein-coupled receptors, has directly enabled the di
162 o and in vivo and that GPRC5B, but not other G protein-coupled receptors, physically interacts with I
165 GABBR2 inhibits neuronal activity through G protein-coupled second-messenger systems and RUFY3 is
167 The beta(1)-adrenoceptor (beta(1)AR) is a G-protein-coupled receptor (GPCR) that couples(1) to the
169 qRT-PCR analysis indicated the expression of G-protein-coupled receptor 68 gene (Gpr68) and acid-sens
170 84 is a medium chain free fatty acid-binding G-protein-coupled receptor associated with inflammatory
172 uggesting that the pathway activated by this G-protein-coupled receptor is causing light-induced phot
177 ntify signaling mechanisms downstream from a G-protein-coupled receptor, the vasopressin V2 subtype r
184 ity-modifying proteins (RAMPs) interact with G-protein-coupled receptors (GPCRs) to modify their func
187 uncover a multi-RhoGEF complex downstream of G-protein-coupled receptors controlling CDC42-RHOA cross
188 rane bundle represent the mechanism by which G-protein-coupled receptors convert an extracellular che
189 lored if ligands of therapeutically relevant G-protein-coupled receptors could be discovered by struc
192 tributes to PF-PC LTP.SIGNIFICANCE STATEMENT G-protein-coupled receptors modulate the release machine
193 receptors (PARs) are a four-member family of G-protein-coupled receptors that are activated via prote
194 ous system development, including a suite of G-protein-coupled receptors that control physiology and
195 licit host production of mediators acting on G-protein-coupled receptors to regulate airway tone.
200 sual rhodopsin is an important archetype for G-protein-coupled receptors, which are membrane proteins
202 vely, our data show that differences in GPCR-G protein coupling preferences, and the Galpha(o) substr
203 ndertakes an atypical mode of activation and G protein coupling that features a different set of key
204 mon mechanism of class B GPCR activation and G protein coupling, and provide a paradigm for studying
205 nderstanding of class F receptor activation, G protein coupling, conformation-based functional select
207 nist selectivity, and lack of activation and G protein-coupling knowledge have hindered the developme
208 in that is proximal to the N terminus of the G protein-coupling seven-transmembrane-spanning bundle.
209 e near intracellular loop (ICL) 2/TM3 at the G-protein-coupling interface, suggesting a mechanism of
210 tutive activity, as well as by enhancing its G protein-dependent signaling and blocking the recruitme
213 nosine diphosphate release, GTP binding, and G protein dissociation studies revealed much slower rate
214 icient deposition of variety of molecules (e.g. proteins, dyes, drugs, biomarkers, amino acids) based
216 s against G-proteins, or a dominant negative G-protein eliminated the increase in GSC division freque
217 the A4G point mutation (2stop+A4G) restored G protein expression but retained lower F protein levels
219 espite the loss of RGS in many monocots, the G-protein functional networks are maintained, and Galpha
220 ping revealed a druggable site formed by the G protein fusion loops that has not previously emerged a
222 and its selective coupling to the inhibitory G protein (G(i)) is vital for pharmaceutical research ai
229 process is the activation of heterotrimeric G-protein Gs by beta(1)-ARs, leading to increased heart
230 thus mice lacking the stimulatory subunit of G-protein (Gsalpha) in osteocytes (Dmp1-Gsalpha(KO) mice
231 GPCRs) functionally couple to heterotrimeric G proteins has been emerging in incremental steps, but a
234 ough class A GPCRs are capable of activating G proteins in a monomeric form, they can also potentiall
238 ally viewed as receptors whose signaling via G proteins is delimited to the plasma membrane, it is no
239 ed receptors, the activity of heterotrimeric G proteins is modulated by many cytoplasmic proteins.
240 of habituation to high protein intake (>2.1 g protein . kg LBM-1 . d-1) led to a significantly highe
241 no acid changes in the hypervariable part of G protein may have altered functions and/or changed its
244 te that GBA motifs have versatility in their G-protein-modulating effect, i.e. they can bind to Galph
245 texts, from characterizing cancer-associated G-protein mutants to neurotransmitter signaling in prima
246 g (RGS) proteins are an integral part of the G-protein networks; however, these are lost in many mono
247 of evidence prioritized protein-coding gene G Protein Nucleolar 3 (GNL3) as a BD risk gene, with int
249 us, molecules with large bias factors toward G protein or beta arrestin are required for investigatin
251 ith specificity for different heterotrimeric G-proteins or for other G-proteins, such as Rho GTPases.
252 RNA-Interference (RNA-i) constructs against G-proteins, or a dominant negative G-protein eliminated
254 ward G protein signaling, and the weaker the G protein partial agonism is the greater the apparent bi
255 scuss their discovery of a novel function of G protein pathway suppressor 2 (GPS2) in promoting eryth
257 he active moieties into a shell structure (e.g., protein, polysaccharide or lipid-based material).
258 e transport of multiple cytoplasmic cargo (e.g., proteins, protein aggregates, lipid droplets or orga
260 s in males because of estrogen regulation of G protein receptor kinase (GRK); pretreatment of ovary-i
261 etagamma and nanoluciferase-tagged truncated G protein receptor kinase 3, an increase in BRET signal
262 naive animals, pharmacological inhibition of G-protein receptor kinase (GRK2/3) with compound 101 blo
269 in signaling is provided by the regulator of G protein signaling (RGS) proteins that deactivate G pro
270 nd that the expression level of regulator of G protein signaling 12 (RGS12) was significantly reduced
271 to understand the functions of regulator of G protein signaling 4 (RGS4), a cytoplasmic protein expr
272 Recordings from mice lacking Regulator of G protein Signaling 6 (RGS6) revealed that RGS6 exerts a
273 vation of the u-opioid receptor (MOR) toward G protein signaling and away from other pathways, such a
274 O) mice, the researchers revealed a shift in G protein signaling from the Gs family to the Gq family.
275 The control over the extent and timing of G protein signaling is provided by the regulator of G pr
276 ially act at mu-opioid receptors to activate G protein signaling over betaarrestin2 recruitment produ
277 dified rodent models suggest that activating G protein signaling pathways while avoiding phosphorylat
278 ar detail on the recognition of regulator of G protein signaling protein 2 (RGS2) by its E3 ligase, i
279 9, which preferentially activated downstream G protein signaling to a greater extent than beta-arrest
280 shown to exhibit low intrinsic efficacy for G protein signaling when ceiling effects are properly ac
281 pparent but erroneous MOR ligand bias toward G protein signaling, and the weaker the G protein partia
282 OR) can alleviate pain through activation of G protein signaling, but they can also induce beta-arres
286 within this region highlighted regulator of G-protein signaling 4 (Rgs4) within laser-capture micro-
287 attributing biological significance to their G protein signalling function still presents a major cha
288 One receptor can couple to more than one G protein subtype, and the coupling efficiency varies de
290 eatic islets, we investigated the effects of G protein subunit beta 5 (Gnb5) knockout on insulin secr
291 or by using a conditional knockout mouse for G protein subunit Galphai2, which is essential for V1R s
293 membrane protrusive activity is promoted by G proteins that deplete phosphatidylinositol 4,5-bisphos
294 nterface, suggesting a mechanism of engaging G-proteins that may have a distinct dependence on PIP(2)
295 g that dampen the activity of heterotrimeric G proteins through their GTPase-accelerating protein (GA
296 peptide derived from a non-GPCR regulator of G-proteins to a small plant protein domain, such that li
297 ng molecule in plants with a requirement for G-proteins to mediate signal transduction, a situation s
299 m focusing on the differential engagement of G proteins versus beta-arrestins are commonly limited by
300 ive approaches to manipulate the activity of G-proteins with high precision are crucial to understand